The Phase 3 data from Massachusetts-based company Biogen and Japanese drugmaker Eisai showed that the drug lecanemab reduced brain decline in nearly 27% of patients.
Subscribe to WMUR on YouTube now for more: [ Ссылка ]
Get more Manchester news: [ Ссылка ]
Like us: [ Ссылка ]
Follow us: [ Ссылка ]
Instagram: [ Ссылка ]
![CUANDO SE TE MOJA LA TARE - PHONK [Super Slowed + Reverb]](http://i.ytimg.com/vi/jmCqMF6bFjE/mqdefault.jpg)
![CUANDO SE TE MOJA LA TARE - PHONK [Super Slowed + Reverb]](https://i.ytimg.com/vi/jmCqMF6bFjE/mqdefault.jpg)